Results for “”

Entry Author Date Location
Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment 01/22/20 National
Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits 01/22/20 New York
CEOs of Women’s Health Companies Fight to Open Investment Floodgates 01/22/20 San Diego
After Ending Cancer Drug Program, Halozyme Predicts Profits in 2020 01/21/20 San Diego
Of Science and Sea Urchins: Researchers Plumb Oceans for Biological Insights 01/21/20 Boston
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers 01/17/20 San Francisco
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
BioCryst Pharma Promotes Charles Gayer to Chief Commercial Officer 01/16/20 Raleigh Durham
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal 01/16/20 Boston
Adaptimmune Appoints Elliot Norry Chief Medical Officer 01/16/20 National
Event Announcement: Xcelerating Life Sciences San Diego 01/16/20 National
Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference 01/16/20 Boston
Disarm Therapeutics Names Scott Holmes Chief Financial Officer 01/15/20 Boston
Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D 01/15/20 New York
Xcelerating Life Sciences San Diego 01/15/20 San Diego
Phage Therapy Firm APT Lands DoD Contract for Antibiotic Alternative 01/15/20 National
FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data 01/14/20 National
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery 01/14/20 National
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline 01/14/20 New York
Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive 01/14/20 San Diego
NeoGenomics Nabs Human Longevity’s Oncology Division for $37M 01/13/20 National
Biogen Adds Another Neuro Drug to Pipeline in Deal With Pfizer 01/13/20 Boston
Incyte Commits $900M to MorphoSys for Rights to Lymphoma Drug 01/13/20 National
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans 01/13/20 Boston
Roche Pays $40M to Use Amunix Pharma’s Half-Life Extension Tech 01/13/20 National
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial 01/13/20 San Francisco
Neurocrine, in Second Epilepsy Deal, Pairs With Swiss Biotech Idorsia 01/11/20 San Diego
Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira 01/10/20 Indiana
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Biogen Teams Up With Startup CAMP4 to Scout for New Neuro Drugs 01/10/20 Boston
Page 1 of 2119 next page »

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Carbonite
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2020, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.